Annovis Bio, Inc.(ANVS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ANVS Annovis Bio, Inc.

Market Closed 10-16 16:00:00 EDT

0.9934

-0.0566

-5.39%

盘后0.9934

+0.00000.00%

19:30 EDT

High1.08	Low0.9870	Vol641.42K
Open1.06	D1 Closing1.05	Amplitude8.86%
Mkt Cap42.26M	Tradable Cap35.31M	Total Shares42.54M
T/O652.00K	T/O Rate1.80%	Tradable Shares35.55M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ANVS","market":"US","secType":"STK","nameCN":"Annovis Bio, Inc.","latestPrice":0.9934,"timestamp":1792180800000,"preClose":1.05,"halted":0,"volume":641423,"hourTrading":{"tag":"盘后","latestPrice":0.9934,"preClose":0.9934,"latestTime":"19:30 EDT","volume":119,"amount":118.2712,"timestamp":1792193404217,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.05390476190476199,"floatShares":35545300,"shares":42541900,"eps":-1.789521,"marketStatus":"Market Closed","change":-0.0566,"latestTime":"10-16 16:00:00 EDT","open":1.06,"high":1.08,"low":0.987,"amount":652002.0536812999,"amplitude":0.088571,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.789521,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1792396800000},"marketStatusCode":7,"adr":0,"listingDate":1580274000000,"exchange":"NYSE","adjPreClose":1.05,"preHourTrading":{"tag":"盘前","latestPrice":1.044,"preClose":1.05,"latestTime":"07:04 EDT","volume":1501,"amount":1562.0339622000001,"timestamp":1792148681460,"change":-0.006,"changeRate":-0.005714,"amplitude":0.009524},"postHourTrading":{"tag":"盘后","latestPrice":0.9934,"preClose":0.9934,"latestTime":"19:30 EDT","volume":119,"amount":118.2712,"timestamp":1792193404217,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9851020562111106,"impliedVol":1.2375,"impliedVolPercentile":0.6056},"requestUrl":"/m/hq/s/ANVS/tweets","defaultTab":"tweets","newsList":[{"id":"2669375485","title":"Annovis Bio announces partnership with Weave Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2669375485","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669375485?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:10","pubTimestamp":1790165409,"startTime":"0","endTime":"0","summary":"Annovis Bio (ANVS) announced a collaboration with Weave Bio, an AI platform for regulatory content and knowledge management, in support of the plan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/annovis-bio-announces-partnership-with-weave-bio-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/annovis-bio-announces-partnership-with-weave-bio-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VTHR","BK4139","CHAT","QTOC","ARTY","AIPO","AGIX","ANVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669839794","title":"Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of Nda for Buntanetap in Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2669839794","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669839794?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:00","pubTimestamp":1790164801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUA4Y24L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ANVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666437574","title":"Annovis Bio Announces Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666437574","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666437574?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:54","pubTimestamp":1789160083,"startTime":"0","endTime":"0","summary":"Annovis Bio announces special shareholder meetingAnnovis Bio will hold a special shareholder meeting in a telephonic virtual format on Oct. 14, 2026.Shareholders will vote on increasing authorized com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL7vVYYY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664162337","title":"Analysts Are Bullish on Top Healthcare Stocks: Annovis Bio (ANVS), AbbVie (ABBV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664162337","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664162337?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:40","pubTimestamp":1788529214,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Annovis Bio (ANVS), AbbVie (ABBV) and Glaukos (GKOS)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-annovis-bio-anvs-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-annovis-bio-anvs-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1057294990.SGD","FHLC","IE00BN8TJ469.HKD","LU2237443622.USD","PJP","FTXH","LU1074936037.SGD","ABBV","IXJ","BK4585","LU0122379950.USD","MEDX","JDOC","LU2125909593.SGD","IE0002270589.USD","LU0689626769.HKD","LU0472753341.HKD","GLAM","LU1430594728.SGD","ANVS","LU2347655156.SGD","LU1718418525.SGD","IE00BLSP4452.SGD","BK4533","GKOS","LU1923622614.USD","LU0708994859.HKD","AGNG","PPH","XLV","LU1934455194.USD","LU0128526141.USD","SG9999015945.SGD","IE00BSNM7G36.USD","XBI","LU0211327993.USD","HCSG","LU0029864427.USD","LU1732799900.SGD","LABU","RXL","IE00BJJMRZ35.SGD","VHT","LU0211328371.USD","LU0128525929.USD","IYH","IE00BBT3K403.USD","TRUH","SG9999015986.USD","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663090226","title":"Annovis Bio Price Target Cut to $7.00/Share from $8.00 by Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2663090226","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663090226?lang=en_us&edition=fundamental","pubTime":"2026-08-29 01:27","pubTimestamp":1787938020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANVS/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662316180","title":"Annovis Bio price target lowered to $7 from $8 at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2662316180","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662316180?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:00","pubTimestamp":1787871611,"startTime":"0","endTime":"0","summary":"Roth Capital analyst Boobalan Pachaiyappa lowered the firm’s price target on Annovis Bio (ANVS) to $7 from $8 and keeps a Buy rating on the shares....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/annovis-bio-price-target-lowered-to-7-from-8-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/annovis-bio-price-target-lowered-to-7-from-8-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662734819","title":"Annovis Bio to Host Corporate Update Webinar with Live Q&A Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2662734819","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662734819?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:04","pubTimestamp":1787659453,"startTime":"0","endTime":"0","summary":"Annovis Bio to host corporate update webinar with live Q&A sessionAnnovis Bio will host a corporate update webinar on Sept. 2, 2026 at 4:00 p.m. EDT.Founder, President and CEO Maria Maccecchini will p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL471bHv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014013.SGD","IE00BGHQF748.EUR","BK4139","BK4112","IE00BQXX3D17.EUR","LU2210150020.SGD","LU2210149790.SGD","BK4585","IE00B64PRP62.GBP","BCDF","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","BK4588","LU0314104364.USD","IE00BKPKM429.USD","ANVS","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014039.USD","LU2095319765.USD","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662734895","title":"Annovis Bio - Phase 3 Alzheimer's Disease Trial Fully Enrolled; Top-Line Data and Submissions Expected in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2662734895","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662734895?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:04","pubTimestamp":1787659450,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0CX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ANVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662373489","title":"Annovis Bio - Open-Label Alzheimer's Study for Buntanetap to Begin October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662373489","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662373489?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:04","pubTimestamp":1787659450,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0CX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ANVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662509732","title":"Annovis to Host Corporate Update Webinar on September 2, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662509732","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662509732?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659200,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Aug.  25, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350406/0/en/annovis-to-host-corporate-update-webinar-on-september-2-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169590202.USD","BK4181","AD","BK4023","LU1169589451.USD","HST","PD","BK4588","ANVS","BK4139","BK4218","BK4585","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662173365","title":"Annovis Bio Announces Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2662173365","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662173365?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:04","pubTimestamp":1787652298,"startTime":"0","endTime":"0","summary":"Annovis Bio announces special shareholder meetingAnnovis Bio will hold a virtual special shareholder meeting in October 2026.Vote on a charter amendment to double authorized common shares to 140,000,0","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL3DvyLP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660747894","title":"Analysts Offer Insights on Healthcare Companies: Annovis Bio (ANVS) and Acurx Pharmaceuticals (ACXP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660747894","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660747894?lang=en_us&edition=fundamental","pubTime":"2026-08-20 03:40","pubTimestamp":1787168424,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Annovis Bio (ANVS) and Acurx Pharmaceuticals (ACXP) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-annovis-bio-anvs-and-acurx-pharmaceuticals-acxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-annovis-bio-anvs-and-acurx-pharmaceuticals-acxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LU0128526141.USD","BK4581","XLV","ANVS","BK4563","XBI","ACXP","LABU","BK4137","BK4585","HCSG","BK4588","LU0029874061.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660422603","title":"Annovis Bio’s New Long-Term Safety Study Puts Buntanetap Back in the Alzheimer’s Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2660422603","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660422603?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:32","pubTimestamp":1787157125,"startTime":"0","endTime":"0","summary":"Annovis Bio Inc ($ANVS) announced an update on their ongoing clinical study. Annovis Bio Inc. has launched a new study focused on long term safety ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/annovis-bios-new-long-term-safety-study-puts-buntanetap-back-in-the-alzheimers-spotlight?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/annovis-bios-new-long-term-safety-study-puts-buntanetap-back-in-the-alzheimers-spotlight?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660891784","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2660891784","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660891784?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:00","pubTimestamp":1786960800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ·Amer Sports Inc.                                  2Q       .11    6:00 AM. ·Home Depot Inc.                                   2Q      4.73    6:00 AM. ·Pony AI ADR                                     2Q      (.15)   5:00 AM. ·BILL Hldgs Inc                                  4Q       .71    4:01 PM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJ","HTHT","BILL","HSAI","ATHM","FN","CAAP","FLO","ANF","BEKE","MBRX","ADIL","KC","LZB","ADI","COTY","IMTX","FUTU","JKHY","MRKR","LOW","KLAR","AAP","ATAT","MRCY","LYTS","HD","GGAL","FLUX","ALVO","KEYS","ZTO","LONA","BIDU","XP","AS","HAIN","DE","FBRX","DCGO","FLNG","BABA","CNSY","ANVS","IQ","NDSN","BEEM","DOMO","BMA","EL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659154142","title":"Annovis Bio Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659154142","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659154142?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:53","pubTimestamp":1786715587,"startTime":"0","endTime":"0","summary":"Annovis Bio Inc reports results for the quarter ended June 30 - Earnings SummaryAnnovis Bio IncANVS.Nreported a quarterly adjusted loss of 40 cents per share for the quarter ended June 30, lower than ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B0Y8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659966149","title":"Annovis Bio Q2 Loss Widens as R&D Costs Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2659966149","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659966149?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:15","pubTimestamp":1786709731,"startTime":"0","endTime":"0","summary":"Annovis Bio Q2 loss widens as R&D costs riseOverviewUS biotech firm's Q2 net loss per share widened yr/yrCompany fully enrolled pivotal Phase 3 Alzheimer's trial, exceeding original targetQ2 research ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0EG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ANVS","CRMD","PMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659638149","title":"Annovis Bio Q2 EPS $(0.40) Beats $(0.45) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659638149","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659638149?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:10","pubTimestamp":1786709418,"startTime":"0","endTime":"0","summary":"Annovis Bio (NYSE:ANVS) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.45) by 11.11 percent. This is a 25 percent decrease over losses of $(0.32) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61205612/annovis-bio-q2-eps-0-40-beats-0-45-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659514935","title":"Annovis Bio Q2 EPS USD -0.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2659514935","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659514935?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:05","pubTimestamp":1786709135,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nPLXR3MNB5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ANVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659099146","title":"Press Release: Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659099146","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659099146?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:01","pubTimestamp":1786708860,"startTime":"0","endTime":"0","summary":"-- Pivotal Phase 3 Alzheimer's disease  trial is fully enrolled with a. total number of 850 patients, exceeding original projections.-- Parkinson's disease  open-label extension  study has enrolled. 266 patients with full enrollment projected in Q4 2026.-- Annovis will host a corporate update webinar on Wednesday, September 2,-- Patients: The pivotal Phase 3 AD trial includes patients diagnosed with. early AD  who are also positive for plasma pTau217 biomarker,confirming the presence of amyloid and tau pathology in the brain.-- Study design: The study measures cognition  and function. pTau217, and other biomarkers to evaluate changes in disease pathology.The study is designed to test both symptomatic  and. -- Timeline: The Company plans a database lock for the 6-month analysis in. Q1 2027, with the top-line symptomatic data readout anticipated in the. same quarter. The disease-modifying data readout is expected a year. later.Alzheimer's disease -- OLE study-- Start: The AD OLE study is","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","BK4139","PD","DBS","LU1169589451.USD","BK4023","AD","ANVS","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642687","title":"Annovis Bio Inc Expected to Post a Loss of 45 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642687","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642687?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:58","pubTimestamp":1786114699,"startTime":"0","endTime":"0","summary":"Annovis Bio Inc <ANVS.N> expected to post a loss of45cents a share - Earnings PreviewAnnovis Bio IncANVS.N,ANVS.Kis expected to  show no change in quarterly revenue when it reports  results on August ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4441S1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANVS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.annovisbio.com","stockEarnings":[{"period":"1week","weight":-0.179},{"period":"1month","weight":-0.0448},{"period":"3month","weight":-0.4291},{"period":"6month","weight":-0.4688},{"period":"1year","weight":-0.5106},{"period":"ytd","weight":-0.7129}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which is in Phase 3 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.040659},{"month":2,"riseRate":0.285714,"avgChangeRate":0.058949},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.056117},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.132244},{"month":5,"riseRate":0.571429,"avgChangeRate":0.255652},{"month":6,"riseRate":0.428571,"avgChangeRate":0.139284},{"month":7,"riseRate":0.571429,"avgChangeRate":0.075716},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.062756},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.087505},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.093722},{"month":11,"riseRate":0.666667,"avgChangeRate":0.26823},{"month":12,"riseRate":0.333333,"avgChangeRate":0.124011}],"exchange":"NYSE","name":"Annovis Bio, Inc.","nameEN":"Annovis Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Annovis Bio, Inc.(ANVS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Annovis Bio, Inc.(ANVS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Annovis Bio, Inc.,ANVS,Annovis Bio, Inc.股票,Annovis Bio, Inc.股票老虎,Annovis Bio, Inc.股票老虎国际,Annovis Bio, Inc.行情,Annovis Bio, Inc.股票行情,Annovis Bio, Inc.股价,Annovis Bio, Inc.股市,Annovis Bio, Inc.股票价格,Annovis Bio, Inc.股票交易,Annovis Bio, Inc.股票购买,Annovis Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Annovis Bio, Inc.(ANVS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Annovis Bio, Inc.(ANVS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}